Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
August 30 2023 - 04:05PM
Business Wire
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will participate at the following upcoming investor
conferences:
- Citi's 18th Annual BioPharma Conference Date: Wednesday,
September 6, 2023 Location: Boston, MA Format: 1x1 Meetings
- Morgan Stanley 21st Annual Global Healthcare Conference
Date/Time: Tuesday, September 12, 2023 at 12:15 p.m. Eastern Time
Location: New York, NY Format: Fireside Chat and 1x1 Meetings
- TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry
Summit Date/Time: Wednesday, September 20, 2023 at 5:00 p.m.
Eastern Time Location: Virtual Format: Fireside Chat
- Cantor Fitzgerald Global Healthcare Conference
Date/Time: Tuesday, September 26, 2023 at 11:30 a.m. Eastern Time
Location: New York, NY Format: Fireside Chat and 1x1 Meetings
Live webcasts of Acadia’s presentations at the Morgan Stanley,
Cantor Fitzgerald and TD Cowen conferences will be accessible on
the company’s website, www.acadia.com, under the investors section
and an archived recording will be available on the website for
approximately one month following the presentation.
About Acadia Pharmaceuticals
Acadia is advancing breakthroughs in neuroscience to elevate
life. For 30 years we have been working at the forefront of
healthcare to bring vital solutions to people who need them most.
We developed and commercialized the first and only approved
therapies for hallucinations and delusions associated with
Parkinson’s disease psychosis and for the treatment of Rett
syndrome. Our clinical-stage development efforts are focused on
treating the negative symptoms of schizophrenia, Prader-Willi
syndrome, Alzheimer’s disease psychosis and neuropsychiatric
symptoms in central nervous system disorders. For more information,
visit us at www.acadia.com and follow us on LinkedIn and
Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230823759521/en/
Media Contact: Acadia Pharmaceuticals Inc. Deb Kazenelson (818)
395-3043 media@acadia-pharm.com
Investor Contact: Acadia Pharmaceuticals Inc. Jessica Tieszen
(858) 261-2950 ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Nov 2023 to Dec 2023
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Dec 2022 to Dec 2023